Back

dr. E.J. (Eduard) van Beers

dr. E.J. (Eduard) van Beers

Assistant Professor - medical

Show full profile

Research Output (98)

A reply to Moris et al.

van Vuren Annelies J., van Beers Eduard J. Dec 2022, In: American Journal of Hematology. 97 , p. E484

Transfusion burden in early childhood plays an important role in iron overload in Diamond-Blackfan anaemia

de Wilde Jonathan R A, van Dooijeweert Birgit, van Vuren Annelies J, Huisman Elise J, Smiers Frans J, van der Veer Arian, van Wijk Richard, van Solinge Wouter W, Nieuwenhuis Edward E S, van Beers Eduard J, Bartels Marije Nov 2022, In: EJHaem. 3 , p. 1300-1304 5 p.

Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T):a multicentre, open-label, single-arm, phase 3 trial

Glenthøj Andreas, van Beers Eduard J, Al-Samkari Hanny, Viprakasit Vip, Kuo Kevin H M, Galactéros Frédéric, Chonat Satheesh, Porter John, Zagadailov Erin, Xu Rengyi, Oluyadi Abdulafeez, Hawkins Peter, Gheuens Sarah, Beynon Vanessa, Barcellini Wilma, 18 Aug 2022, In: Lancet haematology. 9 , p. e724-e732

Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply

Al-Samkari Hanny, Beynon Vanessa, van Beers Eduard J. 30 Jun 2022, In: The New England journal of medicine. 386 , p. 2538-2539 2 p.

Proton pump inhibition for secondary hemochromatosis in hereditary anemia:a phase III placebo-controlled randomized cross-over clinical trial.

van Vuren Annelies, Kerkhoffs Jean Louis, Schols Saskia, Rijneveld Anita, Nur Erfan, Peereboom Dore, Gandon Yves, Welsing Paco, van Wijk Richard, Schutgens Roger, van Solinge Wouter, Marx Joannes, Leiner Tim, Biemond Bart, van Beers Eduard 26 Apr 2022, In: American Journal of Hematology. 97 , p. 924-932 9 p.

Mitapivat versus Placebo for Pyruvate Kinase Deficiency

Al-Samkari Hanny, Galactéros Frédéric, Glenthøj Andreas, Rothman Jennifer A., Andres Oliver, Grace Rachael F., Morado-Arias Marta, Layton D. Mark, Onodera Koichi, Verhovsek Madeleine, Barcellini Wilma, Chonat Satheesh, Judge Malia P., Zagadailov Erin, Xu Rengyi, Hawkins Peter, Beynon Vanessa, Gheuens Sarah, van Beers Eduard J., 14 Apr 2022, In: New England Journal of Medicine. 386 , p. 1432-1442 11 p.

Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease:a phase 2, open-label study

van Dijk Myrthe J, Rab Minke A E, van Oirschot Brigitte A, Bos Jennifer, Derichs Cleo, Rijneveld Anita W, Cnossen Marjon H, Nur Erfan, Biemond Bart J, Bartels Marije, Jans Judith J M, van Solinge Wouter W, Schutgens Roger E G, van Wijk Richard, van Beers Eduard J 5 Apr 2022, In: American Journal of Hematology. 97 , p. E226-E229

Comment on:Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia

Sheehan Vivien A., van Beers Eduard J., Connes Philippe, van Wijk Richard, Rab Minke A.E. 2022, In: British Journal of Haematology. 197 , p. e61-e62

Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias

Al-Samkari Hanny, van Beers Eduard J. Dec 2021, In: Therapeutic advances in hematology. 12

Health-Related Quality of Life and Fatigue in Children and Adults with Pyruvate Kinase Deficiency

Al-Samkari Hanny, van Beers Eduard J, Morton D Holmes, Eber Stefan, Chonat Satheesh, Kuo Kevin H M, Kollmar Nina, Wang Heng, Breakey Vicky, Sheth Sujit, Sharma Mukta, Forbes Peter W, Klaassen Robert, Grace Rachael F 1 Sep 2021, In: Blood Advances. 6 , p. 1844-1853 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet